Marc Wine Science Guru

Marc serves within U.S. government, advising senior officials on advanced and emerging health technologies. He is a recognized health systems and health information technology expert with more than thirty years of experience in the federal and private sectors, is highly focused on Health IT strategy and solutions, health care policy, planning and program management. He is known for building extensive relationships among the federal Health IT Community including wide recognition as an innovative problem solver. Today, Marc is collaborating on medical cybersecurity, precision medicine, and advanced and emerging health IT solutions for empowering the nation’s Veterans including IT digital infrastructure and Learning Health Systems. Marc served within PwC, PricewaterhouseCoopers, in the position of Director Washington Federal Practice, Health IT. He focused on developing business strategies and solutions for health informatics and business process change. Marc served within Northrop Grumman Health Systems Management as Senior Adviser, Federal Health IT; there Marc provided leadership in the collaboration and delivery of the nation’s initial mobile Health Applications, Blue Button for MyHealtheVet, for the first time for Veterans to receive their personal health records on smart phones. While in government, Marc worked on federal health IT sharing; served within U.S. Department of Defense, Telemedicine and Advanced Technology Research Center (TATRC) as well as the U.S. Department of Health and Human Services, Health Resources and Services Administration. He also led hospital systems planning for Greater Boston. Marc served as adjunct professor in Health Informatics within The George Washington University and is the author of many articles and co-authored the book, “Medical Informatics 20/20: Quality and Electronic Health Records through Collaboration, Open Solutions and Innovation.” Marc completed his healthcare background at Harvard University, Brandeis University and the George Washington University.

 

Urgency of Risk in Reproductive Health – A Blockchain Solution

In an article published in The Washington Post in November 2018, the author shared the horrific experiences of women being inseminated with their own doctor’s sperm instead of the sperm donor that the doctor had promised to procure. For at least one victim and her now adult child in Indiana, this reproductive scam felt like rape. The article observes that reproductive fraud is not an isolated event in one or two regions. No, it has occurred across the globe; women struggling with fertility and their children-to-be are exposed to unidentified illness, medical criminality and scandalous abuses of trust, identification, security and safety.

Read More...

Mobilizing Wireless Mobile Strategies: How Can We Get These Advances to Consumers Safely? - Part 2

In Part One of this article, we explored the growing development of mobile technology and the myriad of ways in which it can be deployed, both within and outside the health arena.

Read More...

Mobilizing Wireless Mobile Strategies: How Can We Get These Advances to Consumers Safely? - Part 1

Recently, I participated in a workshop at the National Academy of Sciences, Institute of Medicine, titled “Examining the Impact of Real-World Evidence on Medical Product Development.”

Read More...

Global Disaster, Mobile Health IT and Blockchain Part 2

Part One of this Article focused on the underutilization of existing technologies to improve disaster relief in the field of healthcare. Now we turn to another relatively new technology that has already been applied to the personal health arena; although, there has been considerable discussion as to its merits generally and in healthcare in particular: blockchain.  And, for the record, blockchain will not be the only or last technological advance to infiltrate healthcare.

Read More...

Global Disaster, Mobile Health IT and Blockchain (Part 1)

Start with this new piece of information: the U.S. Centers for Disease Control and Prevention (CDC) just announced that it is cutting off funding used to prevent infectious-disease and epidemics in 39 foreign countries. According to the Wall Street Journal, $582 million in funds designated for work with countries around the globe after the Ebola crisis in 2014 and 2015 will run out at the end of fiscal 2019.

Read More...